Rhythm Pharmaceuticals, Inc. Common Stock (RYTM) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for RYTM. 13F holdings as of 2026-06-30.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| BlackRock | 6,156,902 | $684M | DECREASED |
| State Street | 2,573,529 | $286M | INCREASED |
| Pictet Asset Management Holding | 957,785 | $106M | INCREASED |
| BNY Mellon | 394,044 | $44M | INCREASED |
| Assenagon Asset Management | 186,491 | $21M | NEW |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Alastair Garfield (Chief Scientific Officer) | SELL | 2,150 | $237K | 2026-07-01 |
| Alastair Garfield (Chief Scientific Officer) | EXERCISE | 4,445 | 2026-07-01 | |
| Jennifer L Good (Director) | AWARD | 2,324 | 2026-06-23 | |
| Jennifer L Good (Director) | AWARD | 3,691 | $397K | 2026-06-23 |
| Jennifer L Good (Director) | EXERCISE | 4,712 | 2026-06-23 |
Full institutional holdings, insider history, and congressional trades for Rhythm Pharmaceuticals, Inc. Common Stock on SentiSense.